Cited by 169Ubiquitin and proteasome pathwaysProtein Degradation and InhibitorsProtease and Inhibitor Mechanisms

Site-specific proteasome phosphorylation controls cell proliferation and tumorigenesis.

Open access
Guo, Xing, Wang, Xiaorong, Wang, Zhiping, Banerjee, Sourav, Yang, Jing, Huang, Lan, Dixon, Jack E.·2016·Nature Cell Biology

Abstract

Despite the fundamental importance of proteasomal degradation in cells, little is known about whether and how the 26S proteasome itself is regulated in coordination with various physiological processes. Here we show that the proteasome is dynamically phosphorylated during the cell cycle at Thr 25 of the 19S subunit Rpt3. CRISPR/Cas9-mediated genome editing, RNA interference and biochemical studies demonstrate that blocking Rpt3-Thr25 phosphorylation markedly impairs proteasome activity and impedes cell proliferation. Through a kinome-wide screen, we have identified dual-specificity tyrosine-regulated kinase 2 (DYRK2) as the primary kinase that phosphorylates Rpt3-Thr25, leading to enhanced substrate translocation and degradation. Importantly, loss of the single phosphorylation of Rpt3-Thr25 or knockout of DYRK2 significantly inhibits tumour formation by proteasome-addicted human breast cancer cells in mice. These findings define an important mechanism for proteasome regulation and demonstrate the biological significance of proteasome phosphorylation in regulating cell proliferation and tumorigenesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncb3289

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 169

Authors
Guo, X., Wang, X., Wang, Z., Banerjee, S., Yang, J., Huang, L., & Dixon, J. E.
Affiliations
  • University of California San Diego (US)
  • University of California, Irvine (US)
Corresponding author
  • Guo, Xing
  • Dixon, Jack E.
Venue
Nature Cell Biology
Published
2015-12-14
Volume
18
Issue
2
Pages
202-212
ISSN
  • 1465-7392 (ISSN-L)
  • 1476-4679
OpenAlex
W2195466096
Cited by
169
References
70
Citations by year
2026: 8 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 12 · 2021: 22 · 2020: 21 · 2019: 17 · 2018: 22 · 2017: 20 · 2016: 5
FWCI
6.80
Type
journal article
Language
en
Open access
Locations
  • Nature Cell Biology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Discovery Research Portal (University of Dundee) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
  • National Cancer Institute (R01CA168689, P30CA023100, R01CA174869)
  • National Institute of General Medical Sciences (R01GM074830)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK018024, R01DK018849)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Keywords
19S proteasome, DYRK2, cell cycle regulation, cell proliferation, carcinogenesis, proteasome activity, substrate translocation, breast cancer, 26S proteasome
MeSH terms
ATPases Associated with Diverse Cellular Activities, Dyrk Kinases, Animals, Breast Neoplasms, Cell Cycle, Cell Transformation, Neoplastic, Female, Humans, Mice, Nude, Phosphorylation, Protein-Tyrosine Kinases, Threonine, Time Factors, Transfection, Signal Transduction, Gene Expression Regulation, Neoplastic, Protein Serine-Threonine Kinases, RNA Interference, Cell Line, Tumor, Proteasome Endopeptidase Complex, Tumor Burden, Cell Proliferation, Proteolysis, CRISPR-Cas Systems, Heterografts

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review